Seelos Therapeutics Inc (SEELQ)

[value1008]

As part of this discussion, isn't APRI going to get some milestone payments of around $1.5 - $2.0 million each when specific launches by pharma partners happen--e.g., in UK by Takeda, in France by Majorelle, and in Germany and all those northern countries by Sandoz (not to mention Bracco in Italy, Abbot in Canada, and Recordati and its territories)? That could easily add $5M to $6M this year in addition to whatever a Femprox partnership deal might bring upfront to APRI.